Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

AMETEK Inc.

AME

NEUTRAL

May 28, 2026

Research Conclusion

AMETEK is a high-quality industrial compounder fairly valued at current prices ($226.38), trading near the midpoint of our $215–$255 fair value range. The probability-weighted target of $228 implies ~1% upside. The thesis is intact (ROIC durability, AGM playbook continuity, balance sheet strength), but the 28x forward P/E does not offer asymmetric upside from current levels. Recommended action: Hold for existing positions; accumulate on pullback to $200-210; trim above $260.

Company Overview & Moat Assessment

AMETEK Inc. (NYSE: AME) is a $52B-market-cap diversified industrial compounder operating ~135 differentiated businesses across two segments — Electronic Instruments Group (EIG, ~70% of FY25 revenue, ~28% op margin) and Electromechanical Group (EMG, ~30%, ~24% op margin). FY25 revenue $7.4B (+6.6% YoY) with adjusted EPS $7.43 and FCF $1.67B (22.6% margin). The franchise compounds via the AMETEK Growth Model: roughly +3% organic growth + +3pts M&A contribution + +30-40bps annual margin expansion, with ROIC sustaining 12-13% over a decade. Led by CEO David Zapico (35-year veteran, CEO since 2016).

▲ Bull Case

  • Order/Backlog Acceleration: Q1 2026 orders hit $2.2B record (+22% organic). Backlog $3.87B. EMG segment saw +16% organic order growth, providing 6-month forward revenue visibility and setting up beat-and-raise pattern through 2H 2026.
  • M&A Engine + AGM Playbook: $10B+ deployed over past decade at 13-15% year-3 ROIC. Balance sheet flex (net debt/EBITDA 0.8x) provides $3-4B additional capacity. FARO + Paragon represent highest-quality recent vintage. Continued cadence of $1.0-1.3B/yr through FY30 sustains compounding algorithm.
  • Margin Expansion with Operational Leverage: Q1 2026 core operating margin 27.9% (+160bps YoY). Long-term trajectory: 21.0% (FY17) → 25.8% (FY25) = 480bps over 8 years. Runway exists via FARO integration, Paragon scale-out, aerospace LTA pricing. Adj op margin could reach ~28% by FY27.

▼ Bear Case

  • Valuation Demands Perfection: 28x forward P/E trades at meaningful premium to peer median (P/E 23x; EV/EBITDA 18x). Premium justified by ROIC + balance sheet, but if organic growth slows from +3.5% to +1-2% or operational hiccup occurs, multiple compression toward 25x = $180-200/share (-15 to -20%).
  • Order Surge May Reflect Tariff Pull-Forward: Q1 2026's +22% organic orders is genuine but composition unclear. With Section 301 tariffs in place, customers may have pulled forward to lock in pre-tariff pricing. If 30-50% of surge is pull-forward, 2H 2026-1H 2027 sees book-to-bill drop below 1.0x.
  • M&A Multiple Inflation Erodes Compounding: Acquisition multiples have crept from 6-8x EBITDA (2010s) to 8-10x recent deals. If trend continues and PE-driven private market remains competitive, marginal ROIC math degrades. If next 3-year M&A delivers 10-12% marginal ROIC (vs. historical 14-16%), compounder thesis weakens materially.
Primary Debate on Wall Street

The Street's central question is 'How much of Q1 2026's order strength is durable?' Consensus anchored on FY26 EPS $8.00 (guide $8.04) and FY27 EPS $8.47. Bull variant: $8.20-$8.30 FY26 + $8.65 FY27; bear variant: <$7.90 FY26 if Q2 normalizes. Median analyst PT $255 (range $200-$290). Secondary debates: Is FARO's 8-10x pre-synergy multiple the new normal? Should AMETEK trade as compounder (peer ROP 30x) or cyclical (peer FTV 22x)? When does CEO succession occur (Zapico is 65)?

Top Catalysts
  • Q2 2026 earnings (late July 2026) — order durability and sustainability test
  • Q3 2026 + FY26 guidance reset (Oct 2026) — confirmation of beat-and-raise trajectory
  • Boeing 737 production rate ramp (2H 2026) — aerospace supercycle tailwind
  • Defense budget appropriations (Sept-Oct 2026) — EMG segment support if passed
Top Risks
  • Tariff/trade escalation — Section 301 expansion could compress margins 100-300bps and disrupt order dynamics
  • Industrial capex cycle reversal — End-market cyclicality (aerospace, automation, data center) could turn sharply despite current pricing
  • Currency translation (USD strength) — Strong dollar headwind to 35-40% of international revenues

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/AME/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.